May is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical industry can do more to address the mental health crisis.
The stigma of mental health disorders is slowly disappearing, and that’s a very good thing. You see evidence of this everywhere: on TV and social media, in ad reads on podcasts, even in the traditionally don’t-show-weakness world of professional sports. There is growing acceptance of discussions around mental health.
Unfortunately, despite this cultural change, the prevalence of mental health disorders appears to be increasing, and well-known examples of its unfortunate consequences are all too common.
Medication is a huge part of maintaining mental health for millions of Americans, but clearly the pharmaceutical industry is facing challenges in addressing this problem. I see three main obstacles to progress: adherence, cost and innovation.